This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: New York University, Pfizer Corporation. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,729 
1 out of 4,488 
Years Active: 2019
Title: Jeanne Sue Magram: Innovator in Fusion Protein Technology
Introduction
Jeanne Sue Magram is a notable inventor based in Croton-on-Hudson, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins that have potential therapeutic applications.
Latest Patents
Magram holds a patent for FGF23 c-tail fusion proteins. This patent discloses fusion proteins comprising a FGF-23 c-tail protein fused to a heterologous amino acid sequence. These fusion proteins are designed to modulate serum phosphate levels without substantially affecting serum 1, 25 VitD levels. The invention also includes vectors comprising the nucleic acids related to these proteins and host cells that contain these vectors.
Career Highlights
Throughout her career, Jeanne Sue Magram has worked with prestigious organizations such as New York University and Pfizer Corporation. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Magram has collaborated with notable colleagues, including Moosa Mohammadi and Regina Goetz. These partnerships have further enriched her research endeavors and innovations.
Conclusion
Jeanne Sue Magram's work in fusion protein technology exemplifies her commitment to advancing medical science. Her patent on FGF23 c-tail fusion proteins highlights her innovative contributions to biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile